← Open Payments lookup

MITCHELL BRODEY: Open Payments

NPI 1174501498 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,220 in 115 payments from 25 companies in 2025. Trend: 2023 $1,544 · 2024 $2,170 · 2025 $2,220

Food & beverage: $2,220
CompanyPaymentsAmount
Novo Nordisk Inc23$356
ViiV Healthcare Company5$215
Gilead Sciences, Inc.15$212
Madrigal Pharmaceuticals8$210
ABBVIE INC.15$206
AstraZeneca Pharmaceuticals LP5$178
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$95
Bayer Healthcare Pharmaceuticals Inc.5$80
Merck Sharp & Dohme LLC4$78
Boehringer Ingelheim Pharmaceuticals, Inc.4$71

Products named: DOVATO, REZDIFFRA, Rybelsus, Ozempic, AIRSUPRA, CAPLYTA, Kerendia, JARDIANCE.

Industry payments across NY — which companies pay providers there.